A allele significantly increased the chances of HER2 molecular subtype tumours only in a recessive model (OR = 7.996, 95% CI 1.457-43.873, P = 0.017) but not in a dominant one (P = 0.099). This evidence concerns the gene ERBB2 and neoplasm.